A) Toxicity B) Biocompatibility C) Corrosiveness D) Inflammability
A) To induce inflammation B) To provide a structure for cells to grow and organize C) To block cell growth D) To prevent regeneration
A) Chemical stability B) Thermal conductivity C) Fatigue resistance D) Biodegradability
A) Corrosion B) Heavy weight C) High cost D) Biocompatibility
A) Decrease biocompatibility B) Enhanced surface interactions and properties C) Increase toxicity D) Reduce mechanical strength
A) Polyethylene B) Silicone rubber C) PMMA D) Hydroxyapatite
A) Fibroblasts B) Keratinocytes C) Red blood cells D) Macrophages
A) To prevent infections B) To increase toxicity C) To promote inflammation D) To accelerate degradation
A) Astrophysics B) Marine biology C) Quantum mechanics D) Biomaterials science or biomaterials engineering
A) Biomaterials are engineered, while biological materials are naturally produced B) Biomaterials cannot be used in medical applications C) Biological materials are always synthetic D) There is no difference between them
A) Exclusively organic compounds B) Only natural fibers C) Metallic components, polymers, ceramics, or composite materials D) Pure water-based solutions
A) Using only historical data without new testing B) Exclusively through animal testing C) By computational routines predicting molecular effects based on limited in vitro experimentation D) Through random trial and error methods
A) An assembly method that uses magnetic fields. B) The spontaneous aggregation of particles without external forces. C) A process requiring mechanical manipulation to form structures. D) The random distribution of particles in a solution.
A) The spatial scale of the unit cell (lattice parameter). B) The external forces applied to the system. C) The chemical composition of particles. D) The temperature at which assembly occurs.
A) Self-organization. B) Random particle distribution. C) External guidance and control. D) Chemical bonding between particles.
A) 1.5 nm. B) 60 nm. C) 3 nm. D) 70 to 100 nm.
A) 50/50. B) 80/20. C) 70/30. D) About 60/40.
A) Within the mineral phase only. B) At the gaps between collagen fibrils. C) Randomly throughout the matrix. D) On the surface of tropocollagen molecules.
A) 20 to 30 nm layers. B) 60 nm diameter canals. C) "Bricks" with dimensions of 0.5. D) 1 μm diameter rods.
A) Hydroxyapatite. B) Calcium carbonate. C) Collagen. D) Chitin.
A) An amorphous structure. B) A helical pattern. C) A cubic pattern. D) A random distribution.
A) 1 μm. B) 70 to 100 nm. C) 60 nm. D) 20 to 30 nm.
A) ISO 9001 B) ISO 10993 C) ISO 27001 D) ISO 14001
A) Sugars B) Amino acids C) Nucleotides D) Fatty acids
A) Dental filling material B) Artificial skin scaffold C) Bone graft substitute D) Heart valve coating
A) Polyethylene terephthalate B) Calcium sulfate C) Pyrolytic carbon D) Stainless steel
A) Animal skin B) Metal wires C) Synthetic polymers D) Plant fibers
A) 14 different configurations B) 10 different configurations C) 20 different configurations D) 5 different configurations
A) Kevlar B) Dacron C) Spandex D) Nylon
A) Healing process B) Inflammatory reaction C) Immune response D) Foreign body response (FBR)
A) Microstructure level B) Sub atomic level C) Molecular level D) Ultra-structure level
A) 25% B) 60% C) 49% D) 75%
A) Mechanically strong B) Non-biodegradable C) Chemically reactive D) Electrically conductive
A) 20 to 30 nm. B) 3 nm. C) 60 nm. D) 1 μm.
A) 1.5 nm. B) 70 to 100 nm. C) 3 mm. D) Approximately 60 nm.
A) Biomimetics B) Biocompatibility C) Biofabrication D) Biodegradation
A) 1980s B) Later 1960s C) Early 1950s D) 2000s
A) Drug delivery B) Tissue growth stimulation C) Wound closure D) Bone strengthening
A) Healing phase B) Chronic phase C) Resolution phase D) Acute phase
A) Toxic B) Biocompatible C) Brittle D) Non-degradable
A) Alignment B) Shape C) Elasticity D) Size
A) Polyetheretherketone (PEEK) B) Polymers C) Silica D) Liposomes
A) Cellulose B) Starch C) Proteins D) DNA
A) Lymphocytes B) Eosinophils C) Macrophages D) Neutrophils
A) Biocompatibility B) Acute inflammation only C) Graft-versus-host disease D) Foreign body response
A) Contact lenses B) Dental implants C) Joint replacements D) Skin repair devices
A) Immune cells B) No structures are isolated C) Only the damaged tissue D) The implant
A) DNA B) Silk C) Starch D) Cellulose
A) Biodegradable B) Toxic C) Non-biodegradable D) Inert
A) Young's Modulus B) Tensile strength C) Ductility D) Flexural rigidity
A) Polycarbonate (PC) B) Cyclic olefin polymer (COP) C) Polyetherimide (PEI) D) Polypropylene (PP)
A) Elicit a strong immune reaction B) Suppress the immune response entirely C) Avoid any interaction with the immune system D) Direct the immune response rather than circumvent it
A) Flexural rigidity B) Elasticity C) Toughness D) Compressive strength
A) Ceramic B) Stainless steel C) Ivory D) Aluminum
A) X-ray Diffraction B) Mass Spectrometry C) Scanning Electron Microscopy D) Nuclear Magnetic Resonance
A) Macrostructure B) Line defects C) Edge dislocation D) Point defects |